{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:08:06Z","timestamp":1793812086518,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Nature Science Foundation of Shaanxi","award":["2021JQ-396"],"award-info":[{"award-number":["2021JQ-396"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous studies disclosed that a high thyroid stimulating hormone level is an independent risk factor for diabetes peripheral neuropathy (DPN) in subclinical hypothyroidism (SCH) patients with type 2 diabetes mellitus (T2DM). However, whether thyroid metabolism has an effect on DPN in euthyroid T2DM patients remains unknown. The aim of this study was to identify the association between thyroid function and DPN in euthyroid T2DM patients. A set of 580 euthyroid T2DM patients was enrolled in the current study and stratified into DPN and Non-DPN groups. Mann\u2013Whitney U test was performed to analyze the continuous variables of biochemical and thyroid metabolism indicators, and the Chi-square test was used to compare the categorical variables. Spearman correlation analysis was performed to analyze the relationship between clinical indicators and free thyroxine (FT4). By using the logistic regression analysis, the prevalence of DPN in different thyroid function indicators were evaluated. T2DM patients with DPN had obviously lower levels of aspartate aminotransferase (AST), alpha-hydroxybutyric dehydrogenase (\u03b1-HBDH), superoxide dismutase (SOD), calcium (Ca), creatinine (Cr), uric acid (UA), retinol binding protein (RBP), total protein (TP), albumin (ALB), alanine aminotransferase (ALT) and FT4 than the T2DM patients without DPN (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). FT4 was associated with TP, prealbumin (PA), ALB, SOD, anion gap (AG), Ca, chlorine (Cl), UA, RBP, apoprotein A (Apo A), apoprotein B (Apo B), apoprotein E (Apo E), and total cholesterol (TC). According to the FT4 quartile, participants were sequentially divided into four groups to compare the prevalence of DPN between each group. The data suggested that the prevalence of DPN in these four groups was 53.79%, 53.28%, 54.97%, 38.10%, respectively. Moreover, compared with quartile 4, patients in quartile 1, 2, 3 all had a significantly higher risk of DPN (<jats:italic>P<\/jats:italic>\u2009=\u20090.007, <jats:italic>P<\/jats:italic>\u2009=\u20090.011, <jats:italic>P<\/jats:italic>\u2009=\u20090.004). The level of FT4 was negatively correlated with the prevalence of DPN in euthyroid T2DM patients.<\/jats:p>","DOI":"10.1038\/s41598-023-40752-y","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T20:21:44Z","timestamp":1692390104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between thyroid function and diabetes peripheral neuropathy in euthyroid type 2 diabetes mellitus patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Qingyuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banjun","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"40752_CR1","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/dc11-0903","volume":"34","author":"M Charles","year":"2011","unstructured":"Charles, M. et al. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: The ADDITION-Denmark study. Diabetes Care 34, 2244\u20132249. https:\/\/doi.org\/10.2337\/dc11-0903 (2011).","journal-title":"Diabetes Care"},{"key":"40752_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/IJGM.S273807","volume":"13","author":"FAS Aleidan","year":"2020","unstructured":"Aleidan, F. A. S. et al. Prevalence and risk factors for diabetic peripheral neuropathy among Saudi hospitalized diabetic patients: A nested case-control study. Int. J. Gen. Med. 13, 881\u2013889. https:\/\/doi.org\/10.2147\/IJGM.S273807 (2020).","journal-title":"Int. J. Gen. Med."},{"key":"40752_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2337\/db19-1046","volume":"69","author":"BH Braffett","year":"2020","unstructured":"Braffett, B. H. et al. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study. Diabetes 69, 1000\u20131010. https:\/\/doi.org\/10.2337\/db19-1046 (2020).","journal-title":"Diabetes"},{"key":"40752_CR4","doi-asserted-by":"publisher","first-page":"534372","DOI":"10.3389\/fpubh.2020.534372","volume":"8","author":"Y Lu","year":"2020","unstructured":"Lu, Y. et al. Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: Estimates of the INTERPRET-DD study. Front. Public Health 8, 534372. https:\/\/doi.org\/10.3389\/fpubh.2020.534372 (2020).","journal-title":"Front. Public Health"},{"key":"40752_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dsx.2017.09.013","volume":"12","author":"YW Pai","year":"2018","unstructured":"Pai, Y. W., Lin, C. H., Lee, I. T. & Chang, M. H. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus. Diabetes Metab. Syndr. 12, 111\u2013116. https:\/\/doi.org\/10.1016\/j.dsx.2017.09.013 (2018).","journal-title":"Diabetes Metab. Syndr."},{"key":"40752_CR6","doi-asserted-by":"publisher","first-page":"e0220175","DOI":"10.1371\/journal.pone.0220175","volume":"14","author":"YW Pai","year":"2019","unstructured":"Pai, Y. W., Lin, C. H., Lin, S. Y., Lee, I. T. & Chang, M. H. Reconfirmation of newly discovered risk factors of diabetic peripheral neuropathy in patients with type 2 diabetes: A case-control study. PLoS One 14, e0220175. https:\/\/doi.org\/10.1371\/journal.pone.0220175 (2019).","journal-title":"PLoS One"},{"key":"40752_CR7","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3760\/cma.j.issn.0254-6450.2019.12.014","volume":"40","author":"L Qin","year":"2019","unstructured":"Qin, L. et al. Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 40, 1578\u20131584. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2019.12.014 (2019).","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"40752_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4158\/EP-2018-0459","volume":"25","author":"Q Zhen","year":"2019","unstructured":"Zhen, Q. et al. Total body adiposity, triglycerides, and leg fat are independent risk factors for diabetic peripheral neuropathy in Chinese patients with type 2 diabetes mellitus. Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 25, 270\u2013278. https:\/\/doi.org\/10.4158\/EP-2018-0459 (2019).","journal-title":"Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"issue":"493","key":"40752_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/a-0635-0826","volume":"126","author":"FF Zhu","year":"2018","unstructured":"Zhu, F. F. & Yang, L. Z. The association between the levels of thyroid hormones and peripheral nerve conduction in patients with type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes: Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc. 126(493), 504. https:\/\/doi.org\/10.1055\/a-0635-0826 (2018).","journal-title":"Exp. Clin. Endocrinol. Diabetes: Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc."},{"key":"40752_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.diabres.2016.01.018","volume":"115","author":"W Zhao","year":"2016","unstructured":"Zhao, W. et al. A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res. Clin. Pract. 115, 122\u2013129. https:\/\/doi.org\/10.1016\/j.diabres.2016.01.018 (2016).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"40752_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/diacare.23.8.1108","volume":"23","author":"MM Gabir","year":"2000","unstructured":"Gabir, M. M. et al. The 1997 American diabetes association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23, 1108\u20131112. https:\/\/doi.org\/10.2337\/diacare.23.8.1108 (2000).","journal-title":"Diabetes Care"},{"key":"40752_CR12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye, S. et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285\u20132293. https:\/\/doi.org\/10.2337\/dc10-1303 (2010).","journal-title":"Diabetes Care"},{"key":"40752_CR13","doi-asserted-by":"publisher","first-page":"8161797","DOI":"10.1155\/2020\/8161797","volume":"2020","author":"J Zou","year":"2020","unstructured":"Zou, J. & Li, Z. Association between normal thyroid hormones and diabetic retinopathy in patients with type 2 diabetes. BioMed Res. Int. 2020, 8161797. https:\/\/doi.org\/10.1155\/2020\/8161797 (2020).","journal-title":"BioMed Res. Int."},{"key":"40752_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1210\/jc.2006-1718","volume":"92","author":"A Roos","year":"2007","unstructured":"Roos, A., Bakker, S. J., Links, T. P., Gans, R. O. & Wolffenbuttel, B. H. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92, 491\u2013496. https:\/\/doi.org\/10.1210\/jc.2006-1718 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"40752_CR15","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.metabol.2005.05.020","volume":"54","author":"SY Lin","year":"2005","unstructured":"Lin, S. Y., Wang, Y. Y., Liu, P. H., Lai, W. A. & Sheu, W. H. Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metab.: Clin. Exp. 54, 1524\u20131528. https:\/\/doi.org\/10.1016\/j.metabol.2005.05.020 (2005).","journal-title":"Metab.: Clin. Exp."},{"key":"40752_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jcte.2015.02.004","volume":"2","author":"L Petrosyan","year":"2015","unstructured":"Petrosyan, L. Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism. J. Clin. Transl. Endocrinol. 2, 110\u2013113. https:\/\/doi.org\/10.1016\/j.jcte.2015.02.004 (2015).","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"40752_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.18632\/oncotarget.26265","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China. Oncotarget 10, 88\u201397. https:\/\/doi.org\/10.18632\/oncotarget.26265 (2019).","journal-title":"Oncotarget"},{"key":"40752_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/07435800.2019.1690504","volume":"45","author":"X Kong","year":"2020","unstructured":"Kong, X. et al. Association between free thyroxine levels and diabetic retinopathy in euthyroid patients with type 2 diabetes mellitus. Endocr. Res. 45, 111\u2013118. https:\/\/doi.org\/10.1080\/07435800.2019.1690504 (2020).","journal-title":"Endocr. Res."},{"key":"40752_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s42000-018-0051-3","volume":"17","author":"U Zafar","year":"2018","unstructured":"Zafar, U., Khaliq, S., Ahmad, H. U., Manzoor, S. & Lone, K. P. Metabolic syndrome: An update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens) 17, 299\u2013313. https:\/\/doi.org\/10.1007\/s42000-018-0051-3 (2018).","journal-title":"Hormones (Athens)"},{"key":"40752_CR20","doi-asserted-by":"publisher","first-page":"e1783","DOI":"10.1097\/md.0000000000001783","volume":"94","author":"CP Yang","year":"2015","unstructured":"Yang, C. P. et al. Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: The Taiwan diabetes study. Medicine 94, e1783. https:\/\/doi.org\/10.1097\/md.0000000000001783 (2015).","journal-title":"Medicine"},{"key":"40752_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1254\/jphs.11071FP","volume":"118","author":"D Liu","year":"2012","unstructured":"Liu, D., He, Z., Wu, L. & Fang, Y. Effects of induction\/inhibition of endogenous heme oxygenase-1 on lipid metabolism, endothelial function, and atherosclerosis in rabbits on a high fat diet. J. Pharmacol. Sci. 118, 14\u201324. https:\/\/doi.org\/10.1254\/jphs.11071FP (2012).","journal-title":"J. Pharmacol. Sci."},{"key":"40752_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MED.0b013e32833d6d46","volume":"17","author":"X Zhu","year":"2010","unstructured":"Zhu, X. & Cheng, S. Y. New insights into regulation of lipid metabolism by thyroid hormone. Curr. Opin. Endocrinol. Diabetes Obes. 17, 408\u2013413. https:\/\/doi.org\/10.1097\/MED.0b013e32833d6d46 (2010).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"40752_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jacl.2017.08.015","volume":"11","author":"KY Jung","year":"2017","unstructured":"Jung, K. Y. et al. Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function. J. Clin. Lipidol. 11, 1347\u20131353. https:\/\/doi.org\/10.1016\/j.jacl.2017.08.015 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"40752_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4158\/ep-2017-0017","volume":"24","author":"C Seo","year":"2018","unstructured":"Seo, C. et al. Thyroid hormone replacement reduces the risk of cardiovascular diseases in diabetic nephropathy patients with subclinical hypothyroidism. Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 24, 265\u2013272. https:\/\/doi.org\/10.4158\/ep-2017-0017 (2018).","journal-title":"Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"40752_CR25","doi-asserted-by":"publisher","first-page":"e0135233","DOI":"10.1371\/journal.pone.0135233","volume":"10","author":"C Han","year":"2015","unstructured":"Han, C. et al. Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis. PLoS One 10, e0135233. https:\/\/doi.org\/10.1371\/journal.pone.0135233 (2015).","journal-title":"PLoS One"},{"key":"40752_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1530\/eje-15-1061","volume":"174","author":"I Ates","year":"2016","unstructured":"Ates, I. et al. The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto\u2019s thyroiditis. Eur. J. Endocrinol. 174, 727\u2013734. https:\/\/doi.org\/10.1530\/eje-15-1061 (2016).","journal-title":"Eur. J. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40752-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:19:32Z","timestamp":1700345972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40752"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40752-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13499"}}